Subramanian S, Khan F, Hirsch IB. New advances in type 1 diabetes. BMJ. 2024;384:e075681.

Article  CAS  PubMed  Google Scholar 

Gallagher E, Siu HY. Diabetic ketoacidosis as first presentation of type 1 diabetes mellitus in a young child: important differential diagnosis for respiratory distress. Can Fam Physician. 2020;66:425–6.

PubMed  PubMed Central  Google Scholar 

Gregory GA, Robinson TIG, Linklater SE, Wang F, Colagiuri S, de Beaufort C, et al. Global incidence, prevalence, and mortality of type 1 diabetes in 2021 with projection to 2040: a modelling study. Lancet Diabetes Endocrinol. 2022;10:741–60.

Article  PubMed  Google Scholar 

Kahanovitz L, Sluss PM, Russell SJ. Type 1 diabetes—a clinical perspective. Point Care. 2017;16:37–40.

Article  PubMed  PubMed Central  Google Scholar 

ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, et al. 9. Pharmacologic approaches to glycemic treatment: standards of care in diabetes—2023. Diabetes Care. 2023;46:S140–57.

Cleary PA, Orchard TJ, Genuth S, Wong ND, Detrano R, Backlund JY, et al. The effect of intensive glycemic treatment on coronary artery calcification in type 1 diabetic participants of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study. Diabetes. 2006;55:3556–65.

Article  CAS  PubMed  Google Scholar 

Ratner RE, Dickey R, Fineman M, Maggs DG, Shen L, Strobel SA, et al. Amylin replacement with pramlintide as an adjunct to insulin therapy improves long-term glycaemic and weight control in type 1 diabetes mellitus: a 1-year, randomized controlled trial. Diabet Med. 2004;21:1204–12.

Article  CAS  PubMed  Google Scholar 

Beysel S, Unsal IO, Kizilgul M, Caliskan M, Ucan B, Cakal E. The effects of metformin in type 1 diabetes mellitus. BMC Endocr Disord. 2018;18:1.

Article  PubMed  PubMed Central  Google Scholar 

Meyer L, Bohme P, Delbachian I, Lehert P, Cugnardey N, Drouin P, et al. The benefits of metformin therapy during continuous subcutaneous insulin infusion treatment of type 1 diabetic patients. Diabetes Care. 2002;25:2153–8.

Article  CAS  PubMed  Google Scholar 

Dandona P, Ghanim H, Kuhadiya ND, Shah T, Hejna JM, Makdissi A, et al. Liraglutide as an additional treatment to insulin in patients with type 1 diabetes mellitus—a 52-week randomized double-blinded placebo-controlled clinical trial. Diabetes. 2018;67:3–LB.

Danne T, Garg S, Peters AL, Buse JB, Mathieu C, Pettus JH, et al. International consensus on risk management of diabetic ketoacidosis in patients with type 1 diabetes treated with sodium-glucose cotransporter (SGLT) inhibitors. Diabetes Care. 2019;42:1147–54.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Calafiore R, Luca G, Gaggia F, Basta G. Human stem cell therapy for the cure of type 1 diabetes mellitus (T1D): a hurdle course between lights and shadows. Endocrines. 2024;5:465–77.

Article  CAS  Google Scholar 

Wan XX, Zhang DY, Khan MA, Zheng SY, Hu XM, Zhang Q, et al. Stem cell transplantation in the treatment of type 1 diabetes mellitus: from insulin replacement to beta-cell replacement. Front Endocrinol. 2022;13:859638.

Article  Google Scholar 

Zakrzewski W, Dobrzyński M, Szymonowicz M, Rybak Z. Stem cells: past, present, and future. Stem Cell Res Ther. 2019;10:68.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Alvarez CV, Garcia-Lavandeira M, Garcia-Rendueles MER, Diaz-Rodriguez E, Garcia-Rendueles AR, Perez-Romero S, et al. Defining stem cell types: understanding the therapeutic potential of ESCs, ASCs, and iPS cells. J Mol Endocrinol. 2012;49:R89–111.

Article  CAS  PubMed  Google Scholar 

Rippon HJ, Bishop AE. Embryonic stem cells. Cell Prolif. 2004;37:23–34.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Paris F, Pizzuti V, Marrazzo P, Pession A, Alviano F, Bonsi L. Perinatal stem cell therapy to treat type 1 diabetes mellitus: a never-say-die story of differentiation and immunomodulation. Int J Mol Sci. 2022;23:14597.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dulak J, Szade K, Szade A, Nowak W, Józkowicz A. Adult stem cells: hopes and hypes of regenerative medicine. Acta Biochim Pol. 2015;62:329–37.

Article  CAS  PubMed  Google Scholar 

Karami Z, Moradi S, Eidi A, Soleimani M, Jafarian A. Induced pluripotent stem cells: generation methods and a new perspective in COVID-19 research. Front Cell Dev Biol. 2023;10:1050856.

Article  PubMed  PubMed Central  Google Scholar 

Yu Z, Pestell TG, Lisanti MP, Pestell RG. Cancer stem cells. Int J Biochem Cell Biol. 2012;44:2144–51.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sarang S, Viswanathan C. Umbilical cord derived mesenchymal stem cells useful in insulin production—another opportunity in cell therapy. Int J Stem Cells. 2016;9:60–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Silva IBB, Kimura CH, Colantoni VP, Sogayar MC. Stem cells differentiation into insulin-producing cells (IPCs): recent advances and current challenges. Stem Cell Res Ther. 2022;13:309.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jun HS, Park EY. Adult stem cells as a renewable source of insulin-producing cells. Int J Stem Cells. 2009;2:115–21.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mayhew CN, Wells JM. Converting human pluripotent stem cells into beta-cells: recent advances and future challenges. Curr Opin Organ Transplant. 2010;15:54–60.

Article  PubMed  PubMed Central  Google Scholar 

Snowden JA. Rebooting autoimmunity with autologous HSCT. Blood. 2016;127:8–10.

Article  CAS  PubMed  Google Scholar 

Habiba UE, Khan N, Greene DL, Ahmad K, Shamim S, Umer A. Meta-analysis shows that mesenchymal stem cell therapy can be a possible treatment for diabetes. Front Endocrinol. 2024;15:1380443.

Article  Google Scholar 

Ovayolu O, Ovayolu N, Kaplan E, Pehlivan M, Karadag G. Symptoms and quality of life: before and after stem cell transplantation in cancer. Pak J Med Sci. 2013;29:803–8.

Article  PubMed  PubMed Central  Google Scholar 

Liu Y, Guo LB, Xu JK. Amniotic stem cell transplantation therapy for type 2 diabetes: 3 years’ follow-up report. Eur Rev Med Pharmacol Sci. 2016;20:3877–85.

CAS  PubMed  Google Scholar 

Gu Y, Gong C, Peng X, Wei L, Su C, Qin M, et al. Autologous hematopoietic stem cell transplantation and conventional insulin therapy in the treatment of children with newly diagnosed type 1 diabetes: long term follow-up. Chin Med J (Engl). 2014;127:2618–22.

PubMed  Google Scholar 

Black JB, Adler AF, Wang HG, D’Ippolito AM, Hutchinson HA, Reddy TE, et al. Targeted epigenetic remodeling of endogenous loci by CRISPR/Cas9-based transcriptional activators directly converts fibroblasts to neuronal cells. Cell Stem Cell. 2016;19:406–14.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Karpov DS, Sosnovtseva AO, Pylina SV, Bastrich AN, Petrova DA, Kovalev MA, et al. Challenges of CRISPR/cas-based cell therapy for type 1 diabetes: how not to engineer a “Trojan horse.” Int J Mol Sci. 2023;24:17320.

Article  CAS  PubMed  PubMed Central  Google Scholar 

D’Addio F, Valderrama Vasquez A, Ben Nasr M, Franek E, Zhu D, Li L, et al. Autologous nonmyeloablative hematopoietic stem cell transplantation in new-onset type 1 diabetes: a multicenter analysis. Diabetes. 2014;63:3041–6.

Article  PubMed  Google Scholar 

Wu Q, Zheng S, Qin Y, Zheng X, Chen H, Yang T, et al. Efficacy and safety of stem cells transplantation in patients with type 1 diabetes mellitus-a systematic review and meta-analysis. Endocr J. 2020;67:827–40.